Literature DB >> 3058971

The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis.

X Janssens1, E M Veys, G Verbruggen, L Declercq.   

Abstract

Sensitivity and specificity of antiperinuclear factor (APF) determination were assessed in 127 patients with classical or definite rheumatoid arthritis (RA). The control population consisted of 262 patients with rheumatic complaints other than RA. Our results showed a sensitivity of 86.6%, a specificity of 96.2% and a Youden index of 82.8% for APF in RA. In 14.2% of the total population with RA the rheumatoid factor (RF) became negative in the course of the disease; all but one were found to be actually APF positive. Of the population with RA analyzed, 8.6% were consistently RF negative but APF positive. In view of its strong sensitivity and specificity for RA, APF determination is a valuable serological tool for the diagnosis of the disease. In APF positive, RF negative patients with RA the prognosis seems to be poor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3058971

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

Review 1.  Rheumatology.

Authors:  R A Asherson; R Cervera; D P D'Cruz; G R Hughes
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

2.  Antiperinuclear factor in juvenile rheumatoid arthritis.

Authors:  G Nesher; T L Moore; M W Grisanti; E el-Najdawi; T G Osborn
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

3.  The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies.

Authors:  M Sebbag; M Simon; C Vincent; C Masson-Bessière; E Girbal; J J Durieux; G Serre
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

4.  Anti-perinuclear factor compared with the so called "antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides.

Authors:  C Vincent; F de Keyser; C Masson-Bessière; M Sebbag; E M Veys; G Serre
Journal:  Ann Rheum Dis       Date:  1999-01       Impact factor: 19.103

5.  Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin.

Authors:  R M Hoet; A M Boerbooms; M Arends; D J Ruiter; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

6.  The perinuclear factor, a rheumatoid arthritis-specific autoantigen, is not present in keratohyalin granules of cultured buccal mucosa cells.

Authors:  R M Hoet; R A Voorsmit; W J Van Venrooij
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

7.  Occurrence of antiperinuclear, antikeratin, and anti-RA 33 antibodies in juvenile chronic arthritis.

Authors:  C Gabay; A M Prieur; O Meyer
Journal:  Ann Rheum Dis       Date:  1993-11       Impact factor: 19.103

8.  Antiperinuclear factor: a useful test for the diagnosis of rheumatoid arthritis.

Authors:  S Muñoz-Fernández; R Alvarez-Doforno; M Cuesta; A Balsa; G Fontán; J Gijón-Baños
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

9.  Attitudes to early rheumatoid arthritis: changing patterns. Results of a survey.

Authors:  D Aletaha; G Eberl; V P K Nell; K P Machold; J S Smolen
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

10.  Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage.

Authors:  O Meyer; C Labarre; M Dougados; Ph Goupille; A Cantagrel; A Dubois; P Nicaise-Roland; J Sibilia; B Combe
Journal:  Ann Rheum Dis       Date:  2003-02       Impact factor: 19.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.